Impact of Treatment Sequencing on Overall Survival in Patients with Transplant-Ineligible Newly Diagnosed Myeloma

BACKGROUND: Because patients with newly diagnosed multiple myeloma (NDMM) do not always receive any treatment beyond first-line (1L) therapy, it is imperative that patients receive the best treatment in the 1L setting. However, the optimal initial treatment remains to be identified. We performed a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonseca, Rafael, Facon, Thierry, Hashim, Mahmoud, Nair, Sandhya, He, Jianming, Ammann, Eric, Lam, Annette, Wildgust, Mark, Kumar, Shaji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Hematologic Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166176/
https://www.ncbi.nlm.nih.gov/pubmed/37002943
http://dx.doi.org/10.1093/oncolo/oyad053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166176/
https://www.ncbi.nlm.nih.gov/pubmed/37002943
http://dx.doi.org/10.1093/oncolo/oyad053

Ejemplares similares